Key facts about Acute myeloid leukemia (AML)
Our solution
They support us
Meet the team
Our mission is to develop innovative therapies that prevent drug resistance, improving cancer patient outcomes
Addressing drug resistance in oncology
Your privacy is very important to us. We will collect and use personal information solely with the objective of responding to your online request.
Need more information ?
Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. It is the most common type of acute leukemia in adults . AML has a poor prognosis due to a high refractory and relapse rate, as leukemic cells become resistant to existing treatments.
We are hiring our R&D Director
Join us! We are looking for a motivated and talented person with a strong background in ImmunoOncology